Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB25FWFCB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,335
Award facts
- Contract value 100% obligated
- $2,335.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Tymlos 80 micrograms dose pen injectors (1.56 milliliters). This firm fixed-price delivery order, valued at $2,335.13, was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
Tymlos is an abaloparatide injection used in the treatment of osteoporosis, representing one of the specialized pharmaceutical products within the broader scope of the parent IDC. Through this delivery order mechanism, the DLA can efficiently procure specific pharmaceutical items as needed to support military medical supply requirements. DMS Pharmaceutical Group's positioning as a primary pharmaceutical supplier to the DLA demonstrates its established capability to deliver critical medications and biologics to federal healthcare systems across the defense enterprise.
Quick answers
Who was awarded contract SPE2DB25FWFCB?
SPE2DB25FWFCB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FWFCB worth?
The government has obligated $2,335 on SPE2DB25FWFCB.
Is contract SPE2DB25FWFCB an order under another contract?
Yes. SPE2DB25FWFCB is a delivery order under SPE2DB25D9320, an indefinite delivery contract.
Was contract SPE2DB25FWFCB competed?
The extent of competition for SPE2DB25FWFCB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award